{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-053506","form_type":"8-K","ticker":"XAGE","cik":"0001842939","company_name":"Longevity Health Holdings, Inc.","filed_at":"2025-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.094266+00:00","generated_at":"2026-05-23T15:39:20.725424+00:00","sec_items":["1.01","5.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Longevity Health signs merger with 20/20 Biolabs; combined co. valued ~$99M","bullets":["All-stock merger: 20/20 stockholders to own ~50.1% of combined co. (pre-concurrent financing).","Combined co. FY2025 revenue forecast to double to ~$7-8M from ~$3-4M; ~$1M synergies expected.","Post-closing: Jonathan Cohen (20/20 CEO) becomes CEO; Rajiv Shukla remains Chairman.","Concurrent financing to raise min. $4M gross proceeds; also at-market offering for up to $2M common stock.","Closing expected Q3 2025; subject to stockholder approvals, Nasdaq listing, and other conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-053506","json":"https://secwatch.observer/filing/0000950170-25-053506.json","markdown":"https://secwatch.observer/filing/0000950170-25-053506.md","text":"https://secwatch.observer/filing/0000950170-25-053506.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842939/000095017025053506/0000950170-25-053506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842939/000095017025053506/xage-20250411.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T15:39:20.725424+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}